<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04183140</url>
  </required_header>
  <id_info>
    <org_study_id>SEAH</org_study_id>
    <nct_id>NCT04183140</nct_id>
  </id_info>
  <brief_title>Comparison of Radial and Ulnar Artery Intervention in Patients With ST Elevated Myocardial Infarction</brief_title>
  <official_title>Comparation of Transulnar Versus Transradial Approach for Primary Percutaneous Coronary Intervention in Patients With ST-elevated Myocardial Infarction in Terms of Procedure Complications and In-hospital Cardiac Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sakarya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cosansu, Kahraman, M.D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sakarya University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The transulnar approach is known as an alternative procedure for transradial coronary
      angiography due to its safety and applicability. For cardiologists, experienced in
      trans-ulnar access, this access zone is comfortable to use. Because less spasm is developing.
      In addition, no significant difference was found between the transradial and transulnar
      routes in terms of other complications.In the literature, there are no studies comparing
      these two pathways in ST elevation myocardial infarction (STEMI). In this patient group, it
      will be investigated whether transulnar intervention causes similar or less complications
      than transradial intervention, and whether it provides superiority or similarity in terms of
      outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients admitted with STEMI at the cardiology department and admitted to the catheter laboratory for primary percutaneous coronary intervention will be included in the study. There will be two groups in the study.In the first group, patients treated with transulnar access will be included. In the second group, patients using transradial access will be included. Patients will be treated by the same operator respectively. Peri-procedural data and in-hospital cardiac outcome data of patients in both groups will be recorded.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>1 day</time_frame>
    <description>Major and minor neurovascular events (access related) of the arm including pain/motor paralysis/paresthesia, hematoma, pseudoaneurysm, artery spasm, arterial occlusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>in-hospital cardiac outcomes</measure>
    <time_frame>1 week</time_frame>
    <description>the incidence of death, myocardial infarction (MI), urgent target lesion revascularization (TLR), acute heart failure as major adverse cardiac events (MACEs) within the hospital</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>ST Elevated Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Transradial</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transulnar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>primary percutaneous coronary intervention</intervention_name>
    <description>primary percutaneous coronary intervention via transulnar or transradial access</description>
    <arm_group_label>Transradial</arm_group_label>
    <arm_group_label>Transulnar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients over 18 years of age

          -  admitted for primary percutaneous intervention

          -  either of these two routes has not been used in the last week

          -  a sufficient pulse at both routes

        Exclusion Criteria:

          -  cardiogenic shock

          -  stent thrombosis

          -  the use of either of these two arteries in the last 1 week

          -  either of these arteries can not be pulsed or very weak pulsed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kahraman Cosansu</last_name>
    <phone>+905357864725</phone>
    <email>kahraman141@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ersan Tatlı, PhD</last_name>
    <phone>+905056789099</phone>
    <email>ersantatli@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sakarya University Education and Research Hospital</name>
      <address>
        <city>Sakarya</city>
        <state>TR</state>
        <zip>54100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kahraman Cosansu</last_name>
      <phone>+905357864725</phone>
      <email>kahraman141@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ersan Tatlı, PhD</last_name>
      <phone>+905056789099</phone>
      <email>ersantatli@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Roghani-Dehkordi F, Mansouri R, Khosravi A, Mahaki B, Akbarzadeh M, Kermani-Alghoraishi M. Transulnar versus transradial approach for coronary angiography and angioplasty: Considering their complications. ARYA Atheroscler. 2018 May;14(3):128-131. doi: 10.22122/arya.v14i3.1586.</citation>
    <PMID>30349575</PMID>
  </reference>
  <reference>
    <citation>Bi X, Wang Q, Liu D, Gan Q, Liu L. Is the Complication Rate of Ulnar and Radial Approaches for Coronary Artery Intervention the Same? Angiology. 2017 Nov;68(10):919-925. doi: 10.1177/0003319717703226. Epub 2017 Apr 7.</citation>
    <PMID>28387125</PMID>
  </reference>
  <reference>
    <citation>Dahal K, Rijal J, Lee J, Korr KS, Azrin M. Transulnar versus transradial access for coronary angiography or percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv. 2016 Apr;87(5):857-65. doi: 10.1002/ccd.26221. Epub 2015 Sep 2. Review.</citation>
    <PMID>26332022</PMID>
  </reference>
  <reference>
    <citation>Geng W, Fu X, Gu X, Jiang Y, Fan W, Wang Y, Li W, Xing K, Liu C. Safety and feasibility of transulnar versus transradial artery approach for coronary catheterization in non-selective patients. Chin Med J (Engl). 2014;127(7):1222-8.</citation>
    <PMID>24709170</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 15, 2019</study_first_submitted>
  <study_first_submitted_qc>November 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>December 3, 2019</last_update_submitted>
  <last_update_submitted_qc>December 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sakarya University</investigator_affiliation>
    <investigator_full_name>Kahraman Cosansu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Complication</keyword>
  <keyword>Primary Percutaneus Coronary Intervention</keyword>
  <keyword>Radial Artery</keyword>
  <keyword>Ulnar Artery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Decide according to the results of the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

